Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Henderson

Showing results (471-480 of 547) with videos related to

Pageof 55
Sort By:
BMJ Open|March 23, 2019
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocolY K Onno Teng, Ian N Bruce, Betty Diamond, et al.
The Journal of Experimental Medicine|October 23, 1997
Mycobacterium tuberculosis chaperonin 10 stimulates bone resorption: a potential contributory factor in Pott's diseaseS Meghji, P A White, S P Nair, et al.
Investigational New Drugs|January 19, 2000
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapyC J Dimitroff, W Klohs, A Sharma, et al.
Genome Biology and Evolution|October 10, 2017
Northern Spotted Owl (Strix occidentalis caurina) Genome: Divergence with the Barred Owl (Strix varia) and Characterization of Light-Associated GenesZachary R Hanna, James B Henderson, Jeffrey D Wall, et al.
Plos Genetics|March 23, 2012
Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosisLindsay B Henderson, Vishal K Doshi, Scott M Blackman, et al.
European Journal of Human Genetics : EJHG|January 14, 2010
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosisKathryn E McDougal, Deanna M Green, Lori L Vanscoy, et al.
Elife|June 20, 2023
α<sub>1</sub>-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Ca<sup>2+</sup> channel Ca<sub>V</sub>1.2 activity and long-term potentiation in rodentsKwun Nok Mimi Man, Peter Bartels, Peter B Henderson, et al.
Environmental Science & Technology|December 14, 2011
Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollutionMichael Brauer, Markus Amann, Rick T Burnett, et al.
Journal of Water and Health|December 8, 2017
Associations between extreme precipitation and acute gastro-intestinal illness due to cryptosporidiosis and giardiasis in an urban Canadian drinking water system (1997-2009)Bimal K Chhetri, Tim K Takaro, Robert Balshaw, et al.
JCI Insight|October 3, 2023
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapyChirag H Patel, Yi Dong, Navid Koleini, et al.
Pageof 55

Showing results (471-480 of 547) with videos related to

Sort By:
Pageof 55
BMJ Open|March 23, 2019
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocolY K Onno Teng, Ian N Bruce, Betty Diamond, et al.
The Journal of Experimental Medicine|October 23, 1997
Mycobacterium tuberculosis chaperonin 10 stimulates bone resorption: a potential contributory factor in Pott's diseaseS Meghji, P A White, S P Nair, et al.
Investigational New Drugs|January 19, 2000
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapyC J Dimitroff, W Klohs, A Sharma, et al.
Genome Biology and Evolution|October 10, 2017
Northern Spotted Owl (Strix occidentalis caurina) Genome: Divergence with the Barred Owl (Strix varia) and Characterization of Light-Associated GenesZachary R Hanna, James B Henderson, Jeffrey D Wall, et al.
Plos Genetics|March 23, 2012
Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosisLindsay B Henderson, Vishal K Doshi, Scott M Blackman, et al.
European Journal of Human Genetics : EJHG|January 14, 2010
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosisKathryn E McDougal, Deanna M Green, Lori L Vanscoy, et al.
Elife|June 20, 2023
α<sub>1</sub>-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Ca<sup>2+</sup> channel Ca<sub>V</sub>1.2 activity and long-term potentiation in rodentsKwun Nok Mimi Man, Peter Bartels, Peter B Henderson, et al.
Environmental Science & Technology|December 14, 2011
Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollutionMichael Brauer, Markus Amann, Rick T Burnett, et al.
Journal of Water and Health|December 8, 2017
Associations between extreme precipitation and acute gastro-intestinal illness due to cryptosporidiosis and giardiasis in an urban Canadian drinking water system (1997-2009)Bimal K Chhetri, Tim K Takaro, Robert Balshaw, et al.
JCI Insight|October 3, 2023
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapyChirag H Patel, Yi Dong, Navid Koleini, et al.
Pageof 55